These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
263 related items for PubMed ID: 17371631
1. [New principles and possibilities in the treatment of asthma]. Janner JH, Ulrik CS. Ugeskr Laeger; 2007 Mar 12; 169(11):995-7. PubMed ID: 17371631 [Abstract] [Full Text] [Related]
2. Effectiveness of omalizumab in patients with inadequately controlled severe persistent allergic asthma: an open-label study. Niven R, Chung KF, Panahloo Z, Blogg M, Ayre G. Respir Med; 2008 Oct 12; 102(10):1371-8. PubMed ID: 18657960 [Abstract] [Full Text] [Related]
3. Reduction of the total IgE level by omalizumab in children and adolescents. Steiss JO, Strohner P, Zimmer KP, Lindemann H. J Asthma; 2008 Apr 12; 45(3):233-6. PubMed ID: 18415832 [Abstract] [Full Text] [Related]
4. Anti-IgE therapy with omalizumab in asthma and allergic rhinitis. Dodig S, Richter D, Cepelak I, Benko B. Acta Pharm; 2005 Jun 12; 55(2):123-38. PubMed ID: 16179127 [Abstract] [Full Text] [Related]
5. [Omalizumab, recombinant humanized monoclonal antibody anti-IgE -- new fields of studies on the therapeutic indications]. Kupryś-Lipińska I, Kuna P. Pneumonol Alergol Pol; 2009 Jun 12; 77(1):43-51. PubMed ID: 19308909 [Abstract] [Full Text] [Related]
6. The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma. Bousquet J, Cabrera P, Berkman N, Buhl R, Holgate S, Wenzel S, Fox H, Hedgecock S, Blogg M, Cioppa GD. Allergy; 2005 Mar 12; 60(3):302-8. PubMed ID: 15679714 [Abstract] [Full Text] [Related]
7. Management of asthma with anti-immunoglobulin E: a review of clinical trials of omalizumab. Nowak D. Respir Med; 2006 Nov 12; 100(11):1907-17. PubMed ID: 16949266 [Abstract] [Full Text] [Related]
11. Anti-IgE in severe persistent allergic asthma. Fox H. Respirology; 2007 Nov 12; 12 Suppl 3():S22-8; discussion S45-7. PubMed ID: 17956516 [Abstract] [Full Text] [Related]
14. [Pneumology. Anti-IgE antibodies in the treatment of asthma]. Leuenberger P, Sauty A, Rochat T. Rev Med Suisse; 2007 Jan 10; 3(93):56-9. PubMed ID: 17354662 [Abstract] [Full Text] [Related]
15. [Omalizumab, an anti-IgE monoclonal antibody to treat severe asthma]. Michils A, Sternon J. J Pharm Belg; 2006 Jan 10; 61(3):83-7. PubMed ID: 17058881 [Abstract] [Full Text] [Related]
16. Immunoglobulin E: role in asthma and allergic disease: lessons from the clinic. Owen CE. Pharmacol Ther; 2007 Jan 10; 113(1):121-33. PubMed ID: 17000005 [Abstract] [Full Text] [Related]
17. Anti-immunoglobulin E therapy with omalizumab for asthma. Hendeles L, Sorkness CA. Ann Pharmacother; 2007 Sep 10; 41(9):1397-410. PubMed ID: 17698897 [Abstract] [Full Text] [Related]